Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01983969
Title Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Rituximab

Dexamethasone

Busulfan + Melphalan

Azacitidine + Gemcitabine + Vorinostat

Age Groups: adult
Covered Countries USA


No variant requirements are available.